JNK targets p53 ubiquitination and degradation in nonstressed cells

Genes and Development

Volumn 12, Issue 17, 1998, Pages 2658-2663

  Fuchs, Serge Y ^a   Adler, Victor ^a   Buschmann, Thomas ^a   Yin, Zhimin ^a   Wu, Xiangwei ^a   Jones, Stephen N ^b   Ronai, Ze'ev ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PHOSPHOTRANSFERASE;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL STRAIN 3T3; DNA PROTEIN COMPLEX; GENE EXPRESSION REGULATION; GENE MUTATION; GENE TARGETING; GROWTH REGULATION; HALF LIFE TIME; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

EID: 0032169459     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.17.2658     Document Type: Article

References (38)

1. Adler, V., M.R. Pincus, P.W. Brandt-Rauf, and Z. Ronai. 1995. Complexes of p21RAS with JUN N-terminal kinase and JUN proteins. Proc. Natl. Acad. Sci. 92: 10585-10589.
2. Adler, V., M.R. Pincus, T. Minamoto, S. Fuchs, M.J. Bluth, P.W. Brandt-Rauf, F.K. Friedman, R.C. Robinson, J.M. Chen, X.W. Wang, C.C. Harris, and Z. Ronai. 1997. Conformation-dependent phosphorylation of p53. Proc. Natl. Acad. Sci. 94: 1686-1691.
3. Brown, J.P. and M. Pagano. 1997. p53 stability. Biochem. Biophys. Acta 1332: 1-6.
4. Canman, C.E., T.M. Gilmer, S.B. Coutts, and M.B. Kastan. 1995. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes & Dev. 9: 600-611.
5. Chen, J., X. Wu, J. Lin, and A.J. Levine. 1996. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16: 2445-2452.
6. Feldman, R.M.R., C.C. Correl, K.B. Kaplan, and R.J. Deshaies. 1997. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91: 221-230.
7. Friedlander, P., Y. Legros, T. Soussi, and C. Prives. 1996. Regulation of mutant p53 temperature-sensitive DNA binding. J. Biol Chem. 271: 25468-25478.
8. Fritsche, M., C. Haessler, and G. Brandner. 1993. Induction of cellular p53 accumulation of the tumor-suppressor protein by DNA-damaging agents. Oncogene 8: 307-318.
9. Fuchs, S.Y., L. Dolan, R.J. Davis, and Z. Ronai. 1996. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 13: 1531-1535.
10. Fuchs, S.Y., B. Xie, V. Adler, V.A. Fried, R.J. Davis, and Z. Ronai. 1997. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors. J. Biol. Chem. 272: 32163-32168.
11. Fuchs, S.Y., V. Adler, T. Buschmann, X. Wu, and Z. Ronai. 1998a. Mdm2 association with p53 targets its ubiquitination. Oncogene (in press).
12. Fuchs, S.Y., V. Adler, M.R. Pincus, and Z. Ronai. 1998b. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. (in press).
13. Galcheva-Gargova, Z., B. Derijard, I.-H. Wu, and R.J. Davis. 1994. An osmosensing signal transduction pathway in mammalian cells. Science 265: 806-808.
14. Hall, P.A., P.H. McKee, H.P. Menage, R. Dover, and D.P. Lane. 1993. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8: 203-207.
15. Harris, C.C. 1996. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst. 88: 1442-1455.
16. Harvey, D.M. and A.J. Levine. 1991. P53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes & Dev. 5: 2375-2385.
17. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-298.
18. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420: 25-27.
19. Huibregtse, J.M., M. Scheffner, and P.M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10: 4129-4135.
20. Jones, S.N. A.T. Sands, A.R. Hancock, H. Vogel, L.A. Douchouer, S.P. Linke, G.M. Wahl, and A. Bradley. 1996. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2. Proc. Natl. Acad. Sci. 93: 14106-14111.
21. Kern, S.E., K.W. Kinzler, A. Bruskin, D. Jarosz, P. Friedman, C. Prives, and B. Vogelstein. 1991. Identification of p53 as sequence-specific DNA-binding protein. Science 252: 1708-1711.
22. Kubbutat, M.H.G., S.N. Jones, and K.H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387: 299-302.
23. Levine, A. 1997. P53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
24. Li, Z. and P. Coffino. 1996. Identification of a region of p53 that confers liability. J. Biol. Chem. 271:4447-4451.
25. Lin, J., J. Chen, B. Elenbaas, and A.J. Levine. 1994. Several hydrophobic amino acids in the p53 amino terminal domain are required for transcriptional activation, binding to mdm2 and the adenovirus 5 E1B 55kd protein. Genes & Dev. 8: 1235-1246.
26. Maheswaran, S., C. Englert, P. Bennett, G. Heinrich, and D.A. Haber. 1995. The WT1 product stabilizes p53 and inhibits p53-mediated apoptosis. Genes &. Dev. 9: 2143-2156.
27. Maki, C.G., J.M. Huibregtse, and P.M. Howley. 1996. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56: 2649-2654.
28. Maltzman, W. and L. Czyzyk. 1984. UV irradiation stimulate levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4: 1689-1694.
29. Polyak, K., T. Waldman, C. He, K.W. Kinzler, and B. Vogelstein. 1996. Genetic determinants of p53-induced apoptosis and growth arrest. Genes & Dev. 10: 1945-1952.
30. Querido, E., R.C. Marellus, A. Lai, R. Charbonneau, J.G. Teodoro, G. Ketner, and P.E. Branton. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71: 3788-3798.
31. Reihsaus, E., M. Kohler, S. Kraiss, M. Oren, and M. Montenarh. 1990. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells. Oncogene 5: 137-145.
32. Shieh, S.Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damaged induced phosphorylation of p53 alleviates inhibition by Mdm2. Cell 91: 325-334.
33. Siliciano, J.D., C.E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M.B. Kastan. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes & Dev. 11: 3471-3481.
34. Skowyra, D., K.L. Craig, M. Tyers, S.J. Elledge, and J.W. Harper. 1997. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91: 209-219.
35. Tiemann, F., J. Zerrah, and W. Deppert. 1995. Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation. J. Virol. 69: 6115-6121.
36. Treier, M., L. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-jun degradation in vivo is mediated by the δ domain. Cell 78: 787-798.
37. Zambetti, G.P., J. Bargonetti, K. Walker, C. Prives, and A.J. Levine. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes & Dev. 6: 1143-1152.
38. Zhan, Q., F. Carrier, and A.J. Fornace. 1993. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13: 4242-4250.